Sixty-five different potentially dangerous generic drugs manufactured by Actavis Totowa, LLC, one of the world’s largest generic drug manufacturers, were recalled from market last week. Regulators found that the company’s Little Falls, NJ plant didn’t meet safe manufacturing standards for pills. Suppliers (pharmacists and hospitals) of the generic drugs have been asked to return all pharmaceuticals subject to Actavis’ recall.
These drugs include:
Actavis Tablets :
Amibid DM & DM ER tablets; Amitex PSE tablets; Bellamine S tablets; Betaxolol 10 mg and 20 mg tablets USP; Buspirone HCL 5 mg, 10 mg, 15 mg and 30mg tablets Carisoprodol & Aspirin tablets; Carisoprodol, Aspirin & Codeine tablets; Carisoprodol 350mg tablets; Cilostazol tablets 100mg; Choline Magnesium Trisalicylate 500 mg, 750 mg and 1000 mg tablets; Dexchlorpheniramine Maleate 4 mg and 6 mg tablets; Dipyridamole 25 mg, 50mg, and 75 mg tablets; Glyburide 1.5 mg, 3.0 mg and 6.0 mg tablets; Guaifenesin & Codeine Phosphate tablets; Guaifenesin & Phenylephrine tablets; Guanfacine 1.0 mg and 2.0 mg HCl tablets; Hydrocodone & Homatropine tablets; Hydromorphone HCl tablets; Hydroxyzine 10 mg, 25 mg and 50 mg tablets; Hyoscyamine Sulfate 0.125 mg SL; Hyoscyamine Sulfate 0.375mg SR tablets; Hyoscyamine Sulfate 0.125 mg (oral) tablets; Meclizine Chewable 25 mg tablets; Meloxicam 7.5 mg and 15 mg tablets; Meperidine HCl 100 mg and 50 mg tablets; Methenamine Mandelate 0.5 g and 1.0 g tablets; Mirtazapine 15 mg, 30 mg, and 45 mg tablets; Mirtazapine OD tablets, 15 mg, 30 mg and 45 mg; Multi–ret Folic 500 mg tablets; Multi-vita–bets 0.5 mg and 1.0 mg FL & FE tablets; Multi-vita-bets 0.25 mg, 0.5 mg and 1 mg FL tablets; Naltrexone 50mg tablets; Oxycodone HCl 5 mg, 15 mg and 30 mg tablets; Pentazocine & Acetaminophen tablets; Pentazocine & Naloxone tablets; Phenazopyridine HCl 100 mg and 200 mg tablets; Phendimetrazine Tartrate 35mg tablets; Phentermine HCl 37.5 mg tablets; Prenatal Formula 3 tablets; Prenatal Plus 27 mg FE tablets; Prenatal Rx tablets; Quinaretic 10mg/12.5mg, 20 mg/12.5 mg and 20 mg/25 mg tablets; Sodium FL 0.5 mg and 1.0 mg tablets; Tizanidine HCl 2 mg and 4 mg tablets; Trivita 1 mg FL tablets; Vitaplex Plus tablets; Vitaplex tablets (FC); and Yohimbine HCl 5.4 mg tablets.
Actavis Capsules :
Amantadine 100mg capsules; Amidrine capsules; Amigesic 500 mg caplets and 750 mg caplets; Chlordiazepoxide with Clidinium Bromide capsules; Chlorzoxazone 250mg; Cyclobenzaprine HCL 5 mg and 10 mg; Isradipine 2.5 mg and 5 mg capsules; Loxapine 5 mg, 10 mg, 25 mg, and 50 mg capsules; Meperidine & Promethazine capsules; Oxycodone & Acetaminophen 5/500mg capsules; Oxycodone HCl 5 mg capsules; Phentermine HCl 15 mg, 30 mg and 37.5 mg capsules; Rifampin 300mg capsules; Trimethobenzamide 300mg capsules; Trimipramine Maleate 25mg, 50mg, 100mg capsules; Ursodiol capsules, 300mg; and Vitacon Forte capsules.
Tennessee patients taking these Actavis drugs should continue use but see their heath care provider as soon as possible for substitute prescriptions. (Note: These recalled and potentially dangerous pills are only for those made by the Little Falls, NJ facility; other generic Actavis capsules, tablets, and other pills manufactured in other Actavis facilities are not affected by this drug recall.)
Readers of Tennessee Law Blog will remember our previous dangerous drug report for Actavis’s digitek medication recall in May when Actavis recalled lots of the heart medication for manufacturing error. (Some heart pills were mashed together during manufacturing and poison the patient taking the pill.) No word yet if this new Actavis drug recall poses the same threat to patients taking these recalled generic pills.